Soluble AXL as a marker of disease progression and survival in melanoma von Flem-Karlsen, Karine, Nyakas, Marta, Farstad, Inger Nina, McFadden, Erin, Wernhoff, Patrik, Jacobsen, Kari Dolven, Florenes, Vivi Ann, Maelandsmo, Gunhild Mari

Volltext

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy von Magnussen, Gry Irene, Holm, Ruth, Emilsen, Elisabeth, Rosnes, Anne Katrine Ree, Slipicevic, Ana, Flørenes, Vivi Ann

Volltext

AXL inhibition improves BRAF-targeted treatment in melanoma von Nyakas, Marta, Fleten, Karianne Giller, Haugen, Mads Haugland, Engedal, Nikolai, Sveen, Christina, Farstad, Inger Nina, Flørenes, Vivi Ann, Prasmickaite, Lina, Mælandsmo, Gunhild Mari, Seip, Kotryna

Volltext

MX 2 is a novel regulator of cell cycle in melanoma cells von Juraleviciute, Marina, Pozniak, Joanna, Nsengimana, Jérémie, Harland, Mark, Randerson‐Moor, Juliette, Wernhoff, Patrik, Bassarova, Assia, Øy, Geir Frode, Trøen, Gunhild, Flørenes, Vivi Ann, Bishop, David Timothy, Herlyn, Meenhard, Newton‐Bishop, Julia, Slipicevic, Ana

Volltext

Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma von Davidson, Ben, MD, PhD, Hadar, Rivka, MSc, Schlossberg, Anat, BSc, Sternlicht, Tamar, MSc, Slipicevic, Ana, MSc, Skrede, Martina, Risberg, Björn, MD, PhD, Flørenes, Vivi Ann, PhD, Kopolovic, Juri, MD, Reich, Reuven, PhD

Volltext

Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies von Flatmark, Kjersti, Guldvik, Ingrid J., Svensson, Hege, Fleten, Karianne G., Ann Flørenes, Vivi, Reed, Wenche, Giercksky, Karl‐Erik, Fodstad, Øystein, Andersson, Yvonne

Volltext

Dacarbazine and the agonistic TRAIL receptor-2 antibody lexatumumab induce synergistic anticancer effects in melanoma von Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari

Volltext

Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma von DAVIDSON, Ben, ZHEN ZHANG, KLEINBERG, Lilach, MEI LI, FLØRENES, Vivi Ann, WANG, Tian-Li, SHIH, Le-Ming

Volltext

Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance von Hetland, Thea Eline, MD, Nymoen, Dag Andre, MSc, Holth, Arild, BSc, Brusegard, Kjersti, MSc, Flørenes, Vivi Ann, PhD, Kærn, Janne, MD, PhD, Tropé, Claes G., MD, PhD, Davidson, Ben, MD, PhD

Volltext

The fatty acid binding protein 7 (FABP7) is involved in proliferation and invasion of melanoma cells von Slipicevic, Ana, Jørgensen, Kjersti, Skrede, Martina, Rosnes, Anne Katrine Ree, Trøen, Gunhild, Davidson, Ben, Flørenes, Vivi Ann

Volltext

A Three-dimensional Ex Vivo Viability Assay Reveals a Strong Correlation Between Response to Targeted Inhibitors and Mutation Status in Melanoma Lymph Node Metastases von Flørenes, Vivi Ann, Flem-Karlsen, Karine, McFadden, Erin, Bergheim, Inger Riise, Nygaard, Vigdis, Nygård, Vegard, Farstad, Inger Nina, Øy, Geir Frode, Emilsen, Elisabeth, Giller-Fleten, Karianne, Ree, Anne Hansen, Flatmark, Kjersti, Gullestad, Hans Petter, Hermann, Robert, Ryder, Truls, Wernhoff, Patrik, Mælandsmo, Gunhild Mari

Volltext

Expression of inhibitor-of-apoptosis protein family members in malignant mesothelioma von Kleinberg, Lilach, MSc, Lie, Agnes Kathrine, MD PhD, Flørenes, Vivi Ann, PhD, Nesland, Jahn M., MD, PhD, Davidson, Ben, MD, PhD

Volltext

HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases von Hetland, Thea Eline, Holth, Arild, Kærn, Janne, Flørenes, Vivi Ann, Tropé, Claes G., Davidson, Ben

Volltext

Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinoma von Davidson, Ben, McFadden, Erin, Holth, Arild, Brunetti, Marta, Flørenes, Vivi Ann

Volltext

Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma von DAVIDSON, Ben, REICH, Reuven, LAZAROVICI, Philip, FLØRENES, Vivi Ann, NIELSEN, Søren, NESLAND, Jahn M

Volltext

Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions von Slipicevic, Ana, Holth, Arild, Hellesylt, Ellen, Tropé, Claes G, Davidson, Ben, Flørenes, Vivi Ann

Volltext

Soluble AXL is ubiquitously present in malignant serous effusions von Flem Karlsen, Karine, McFadden, Erin, Flørenes, Vivi Ann, Davidson, Ben

Volltext

Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma von KLEINBERG, Lilach, FLØRENES, Vivi Ann, SKREDE, Martina, HIEP PHUC DONG, NIELSEN, Søren, MCMASTER, Michael T, NESLAND, Jahn M, SHIH, Ie-Ming, DAVIDSON, Ben

Volltext

Biological effects induced by insulin‐like growth factor binding protein 3 (IGFBP‐3) in malignant melanoma von Øy, Geir Frode, Slipicevic, Ana, Davidson, Ben, Solberg Faye, Ragnar, M. Mælandsmo, Gunhild, Flørenes, Vivi Ann

Volltext

Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells von Engesæter, Birgit Ø., Sathermugathevan, Menaka, Hellenes, Tina, Engebråten, Olav, Holm, Ruth, Flørenes, Vivi Ann, Mælandsmo, Gunhild M.

Volltext